Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARAP3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | OTUD5 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | MGST2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | KIR3DL1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | SKA1 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
mRNA | MYL10 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | RXRG | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
mRNA | RP11-307N16.6 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
mRNA | CMTM7 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | KRT20 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |